ArticleBMC cancer2024

Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma.

Meletios Dimopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.